Professor of Urology Dan Theodorescu, MD, PhD, plans to study loss of Y chromosome biology and investigate potential therapies for bladder and other cancers.

Patients with high-impact chronic pain had eosinophilia at a higher rate than the general population, according to a new University of Arizona study.

Jennifer Barton, PhD, is spearheading an effort to diagnose ovarian cancer earlier and give high-risk patients a new option.

Researchers from the Department of Orthopaedic Surgery showed how a drug that boosts red blood cells in people with anemia can help quicken the pace of healing nerve injuries in mice.

The CTSA grant, the largest infrastructure and training award from the NIH, supports the translation of research discoveries into improved patient care.

A University of Arizona-led study found that 4-aminopyridine sped up bone fracture repair in mouse models, ramping up the activity of key genes.

Researchers, including Aaron Scott, MD, associate professor of medicine, modified the chemotherapy drug paclitaxel to more effectively target breast and pancreatic cancer tumors.

A study recently published in Nature describes a “previously unrecognized” sense that facilitates communication between the gut and the brain.

A new study led by Dr. Stefano Guerra, professor of medicine, will investigate whether levels of the lung protein CC16 in childhood can predict risk of early chronic obstructive pulmonary disease later in life.

A U of A Cancer Center team led by the Division of Hematology & Oncology’s Drs. Steffan Nawrocki and Jennifer Carew identified a novel biomarker to predict which patients with clear cell renal cell carcinoma may best benefit from a targeted combination therapy involving autophagy inhibition.